看看查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-15 AccNo: 0001047469-17-001623 Size: 8 MB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2017-03-08 AccNo: 0001104659-17-015202 Size: 135 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 美东时间 2017-03-08 盘后 披露财报,预期EPS -0.27 网页链接
$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0001615774-17-000563 Size: 53 KB 网页链接
$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-09 AccNo: 0000902664-17-000925 Size: 106 KB 网页链接
$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-06 AccNo: 0000919574-17-001024 Size: 118 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2017-01-09 AccNo: 0001104659-17-001365 Size: 4 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2017-01-03 AccNo: 0001104659-17-000261 Size: 2 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-12-01 AccNo: 0001104659-16-159923 Size: 32 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-07 AccNo: 0001104659-16-155190 Size: 3 MB 网页链接